The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Uses its C-Terminus to Regulate the A2B Adenosine Receptor by Watson MJ et al.
1Scientific RepoRts | 6:27390 | DOI: 10.1038/srep27390
www.nature.com/scientificreports
The Cystic Fibrosis Transmembrane 
Conductance Regulator (CFTR) Uses 
its C-Terminus to Regulate the A2B 
Adenosine Receptor
Michael J. Watson1, Shernita L. Lee1, Abigail J. Marklew1,2, Rodney C. Gilmore1, 
Martina Gentzsch1,3, Maria F. Sassano1, Michael A. Gray2 & Robert Tarran1,3
CFTR is an apical membrane anion channel that regulates fluid homeostasis in many organs including 
the airways, colon, pancreas and sweat glands. In cystic fibrosis, CFTR dysfunction causes significant 
morbidity/mortality. Whilst CFTR’s function as an ion channel has been well described, its ability to 
regulate other proteins is less understood. We have previously shown that plasma membrane CFTR 
increases the surface density of the adenosine 2B receptor (A2BR), but not of the β2 adrenergic 
receptor (β2AR), leading to an enhanced, adenosine-induced cAMP response in the presence of CFTR. 
In this study, we have found that the C-terminal PDZ-domain of both A2BR and CFTR were crucial 
for this interaction, and that replacing the C-terminus of A2BR with that of β2AR removed this CFTR-
dependency. This observation extended to intact epithelia and disruption of the actin cytoskeleton 
prevented A2BR-induced but not β2AR-induced airway surface liquid (ASL) secretion. We also found 
that CFTR expression altered the organization of the actin cytoskeleton and PDZ-binding proteins in 
both HEK293T cells and in well-differentiated human bronchial epithelia. Furthermore, removal of 
CFTR’s PDZ binding motif (ΔTRL) prevented actin rearrangement, suggesting that CFTR insertion in 
the plasma membrane results in local reorganization of actin, PDZ binding proteins and certain GPCRs.
Cystic fibrosis (CF) is a multi-organ disease caused by genetic mutations in CFTR, a cAMP-regulated anion chan-
nel1, leading to a reduction or ablation in apical membrane CFTR channel activity that is especially visible in the 
lungs, pancreas, GI tract, sweat glands and reproductive systems2. In CF airways, lack of functional CFTR causes 
airway surface liquid (ASL) volume depletion/mucus dehydration, that leads to mucus plugging and chronic 
infection/inflammation that ultimately destroy the lungs3. Extracellular adenosine signals through purinergic 
receptors including the Gs-linked A2B receptor (A2BR) which stimulates adenylate cyclase to raise cAMP and 
activate protein kinase A4,5. Regulation of CFTR by the A2BR is vital for the defense of mucosal surfaces6–8. For 
example, adenosine acts as a reporter molecule in the ASL whose concentration and dilution serve to modulate 
CFTR activity via stimulation of A2BR and hence, to maintain sufficient ASL volume to preserve mucus hydra-
tion9. A failure of this system, due to the lack of the effector (i.e. CFTR), contributes to the ASL depletion/mucus 
stasis seen in CF lung disease that leads to mucus stasis and chronic infections10,11.
CFTR is indirectly anchored to the actin cytoskeleton through filamin, NHERF1, NHERF2 and syntaxin12–14, 
while A2BR has been shown to bind NHERF215. CFTR regulates other apical proteins including ENaC, KIR 
1.1 and SLC26A9, through PDZ-binding via ezrin, NHERF1 and NHERF2, as well as through direct binding 
to CFTR14,16–18. These interactions are robust, and when CFTR-containing patches are excised from the plasma 
membrane, A2BR and signaling proteins such as Gs are also excised, allowing A2BR to regulate CFTR19. Similarly, 
Naren et al. demonstrated that CFTR and the β2 adrenergic receptor (β2AR) exist in an ordered macromolecular 
complex20. There is no a priori reason why CFTR should directly interact with its upstream G-protein-coupled 
receptor (GPCR) since several intermediary proteins, as well as soluble secondary messengers, lie between them 
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in the signal transduction pathway. However, such a macromolecular complex may aid in increasing signal trans-
duction specificity and efficiency in the plasma membrane.
We have previously shown that CFTR enhances A2BR protein expression in the plasma membrane of both 
non-polarized cells (BHKCFTR and HEK293T cells) and well-differentiated, polarized human bronchial epithelial 
cultures (HBECs)21. Lack of CFTR-dependent regulation of A2BR leads to decreased cAMP production, ciliary 
beat frequency, and IL-8 secretion in response to adenosine in CF HBECs. CFTR-A2BR interactions also increase 
upon adenosine-exposure. For example, Forster Resonance Energy Transfer (FRET) between CFTR and A2BR 
acutely increases ~4 fold upon adenosine stimulation21. This interaction is specific for CFTR-A2BR and despite 
existing in a macromolecular complex20, FRET levels between CFTR and the β2AR do not alter upon stimula-
tion with isoproterenol21. Despite having clear effects on CFTR function, little is known regarding how CFTR 
and A2BR interact. Recently, Monterisi et al. have reported (i) that CFTR affects actin and cAMP distribution 
in an airway cell line and that disruption of the actin cytoskeleton with latrunculin abolishes cAMP-dependent 
Cl− efflux22. Since CFTR and A2BR are both connected to the actin cytoskeleton via their PDZ motifs, we have 
tested the hypothesis that agonist-induced CFTR-A2BR clustering and actin organization were dependent on 
C-terminal PDZ interactions.
Figure 1. CFTR affects the near-membrane organization of scaffolding proteins. Open bars, normal or 
CFTR-expressed; closed bars, CF or null as appropriate. (A) Typical Western blot of actin, ezrin, NHERF1 and 
NHERF2 in normal and CF HBECs. (B) Mean densitometry data for apical and sub-apical actin, ezrin and 
NHERF1/2. (C) Representative pseudocolored confocal micrographs taken in X-Z mode showing F-actin, 
ezrin, NHERF1 and NHERF2 staining in normal and CF HBECs. (D) Mean fluorescent intensities taken 
from C. (E) Representative pseudocoloured confocal micrographs taken in X-Y mode showing F-actin, ezrin, 
NHERF1 and NHERF2 localization in HEK cells and HEK cells stably expressing CFTR (HEKCFTR). (F) Mean 
near plasma membrane fluorescence image intensities. All data are representative from images acquired on 
three separate occasions. HBECs were provided from 3 normal and 3 CF (ΔF508/ΔF508) donors. *p < 0.05 
different ± CFTR expression.
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Results
The organization of actin and other scaffolding proteins is disrupted in CF airway epithelia. It 
has previously been shown that CFTR alters actin expression in an airway epithelial cell line (16HBE)22. We tested 
Figure 2. The C-Terminus of CFTR is required for focusing the sub-apical cytoskeleton. (A) Typical 
confocal micrographs taken in X-Y mode of F-actin and NHERF1 in HEK293T cells expressing GFP-
tagged wild-type or ΔTRL CFTR, or non-transfected (null). Scale bar is 25 μm. (B) Mean fluorescent 
intensities taken from confocal micrographs in A. All n = 15. (C) Typical super resolution images of 
wild-type and ΔTRL CFTR (green) expressed in HEK293T cells and counter-stained for F-actin using 
phalloidin-647 (red). Each pixel is 30 nm2 and the scale bar is 2.5 μm. Arrow denotes plasma membrane 
wild-type CFTR. All data are representative from images acquired on three separate occasions. The 
corresponding brightfield images are also shown and the regions imaged in super resolution mode are 
boxed. (D) Pearson’s correlation coefficient (r) for colocalization between wild-type or ΔTRL CFTR and 
F-actin, based on images shown in C. *p < 0.05 different ± CFTR expression. †p < 0.05 different to 0.
Figure 3. Surface CFTR co-localizes with actin. (A) HA-CFTR (green) was labelled with anti-HA primary 
and Alexa488 goat secondary antibody in BHKCFTR cells. The actin cytoskeleton (red) was labelled with 
Phalloidin 568. Images were taken sequentially to ensure full spectral separation and are representative of three 
independent experiments. (B) Mean Pearson’s correlation coefficient (r) for CFTR and actin aligned as per panel 
a (pre-rotation, ●) and after rotating the actin images by 90° (post-rotation, ■). Both n = 16. Inset shows actin 
with 90° rotation. * denotes p < 0.05 different between pre and post-rotation. †p < 0.05 different to 0.
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the hypothesis that this phenomenon was preserved in primary airway epithelial cultures from normal vs. CF 
donors. We also hypothesized that CFTR could also influence the localization of scaffolding/PDZ-binding pro-
teins. To test these hypotheses, we searched in primary HBECs for altered actin, ezrin, NHERF1 and NHERF2 
expression in the presence of wild-type CFTR vs. ΔF508 CFTR that does not traffic to the plasma membrane. 
CFTR had no effect on total actin, ezrin, NHERF1 and NHERF2 protein levels, as measured by Western blotting 
in normal vs. ΔF508 CFTR homozygous CF HBECs (Fig. 1A,B). However, expression of wild-type CFTR induced 
a significant reorganization of actin, ezrin and NHERF2 with more protein being visible at the apical plasma 
membrane, an effect that was diminished in CF/ΔF508-CFTR HBECs (Fig. 1C,D). A similar difference in the 
organization of these proteins could be detected in HEK293T cells expressing wild-type CFTR (Fig. 1E,F).
Since CFTR has previously been shown to interact with actin via its C-terminal PDZ-binding motif, we next 
tested whether deletion of this motif (CFTRΔTRL) affected actin and NHERF1 organization. Indeed, CFTRΔTRL 
did not affect either actin or NHERF1 and cells expressing this construct were similar to null HEK293T cells that 
did not express CFTR (Fig. 2A,B). Further investigation using super resolution microscopy indicated that CFTR 
and actin could be detected in a discrete region at the cell periphery of HEK293T cells that was clearly demarked 
from intracellular CFTR/actin (Fig. 2C). In contrast, both CFTRΔTRL and actin were visible in a more diffused 
pattern throughout the cell and it was hard to differentiate between plasma membrane vs. intracellular CFTR 
(Fig. 2C). The Pearson’s coefficient (r) for wild-type CFTR and actin (phalloidin) was ~0.35, suggesting that the 
two proteins significantly colocalized (Fig. 2D). In contrast, r was significantly reduced to <0 for CFTRΔTRL, 
which indicated that colocalization no longer occurred (Fig. 2D).
We next tested whether surface CFTR could be localized near actin. Accordingly, we visualized surface CFTR 
in BHKCFTR cells without staining intracellular CFTR (Fig. 3). It is important to note that for these experiments, 
surface CFTR was first labelled, and then cells were permeabilized to allow actin labelling with phalloidin. CFTR 
was surface labelled using an anti-HA antibody against the extracellular HA tag. After CFTR labelling, cells were 
permeabilized and actin was probed using phalloidin-568. CFTR was visible at the cell surface and significantly 
co-localized with actin (Fig. 3A,B). As a control for our analysis, we rotated the actin image 90°, which signifi-
cantly reduced the correlation coefficient (Fig. 3B).
Disruption of the actin cytoskeleton leads to altered A2BR, but not β2AR-dependent signaling. 
Adenosine-stimulated, CFTR-mediated Cl− secretion is required for ASL hydration23. Therefore, to determine 
whether a similar relationship existed between A2BR/CFTR-mediated fluid secretion and the cytoskeleton in 
HBECs, we measured ASL height in the presence and absence of cytochalasin D. Actin depolymerization pre-
vented adenosine- but not isoproterenol-stimulated ASL secretion in normal HBECs, suggesting that this effect 
was specific for adenosine/CFTR-mediated ASL secretion (Fig. 4A,B). As an additional control, we also looked 
at the effect of actin disruption on ATP/Ca2+-activated Cl−/ASL secretion and found that cytochalasin D had no 
effect on this parameter (Fig. 4A,B).
Figure 4. Cytochalasin D abolishes adenosine- but not isoproterenol-mediated ASL secretion in normal 
HBECs. HBECs were exposed to vehicle (0.1% DMSO) or 10 μM cytochalasin D (CytD) for 30 min before 
agonist addition. (A) Typical XZ confocal micrographs of ASL (red) taken after 10 min exposure to adenosine, 
isoproterenol and ATP (all at 100 μM) in the presence and absence of 10 μM cytochalasin D in normal HBECs. 
(B) Mean ASL height data. Open bars, control. Closed bars, adenosine; grey bars, isoproterenol; hatched bars, 
ATP. All n = 6. *p < 0.05 different from vehicle. †p < 0.05 different ± cytochalasin D.
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Figure 5. Forskolin and adenosine, but not isoproterenol, elicit cytochalasin D-sensitive CFTR responses. 
HEK293T cells were cultured in 384-well plates and co-transfected with either wild-type CFTR or CFTRΔTRL 
and halide-sensitive YFP. Cells were pretreated for 30 min with 1 μM cytochalasin D or vehicle (0.1% DMSO) 
in media. Using a multiplate reader, fluorescence was obtained at 0.2 Hz. After baseline readings were obtained, 
Cl− in the media was exchanged for I− and agonist or vehicle, and the change in fluorescence over time was 
monitored at 0.2 Hz until a steady state was reached. (A–C) Typical traces showing changes in fluorescence for 
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To test whether CFTR-mediated Cl− secretion was similarly affected in other cell types, we co-expressed 
wild-type CFTR and halide sensitive YFP in HEK293T cells and measured the degree of YFP-quenching upon 
exchange of 100 mM Cl− in the bath solution for 100 mM I− as described24. In the presence of agonist, exchange 
of Cl− in the bath solution for I− gave a rapid quenching of YFP fluorescence which was markedly greater when 
CFTR was co-expressed (Fig. 5A,C,E). Since we cultured cells in 384-well plate format, we were able to generate 
~12 point dose responses for all conditions tested and rather than compare individual data points, we curve-fitted 
each dose response and compared the differences in the curves (Fig. 5B,D,F). Consistent with the data shown 
in Fig. 4, adenosine- but not isoproterenol- stimulation of CFTR diminished after cytochalasin D exposure 
over a range of doses (Fig. 5B,D,F). Forskolin-dependent stimulation of CFTR was also cytochalasin D sensi-
tive (Fig. 5A,D). We also co-expressed CFTRΔTRL with the halide-sensitive YFP and measured its sensitivity to 
adenosine/isoproterenol. CFTRΔTRL is typically expressed at lower levels at the plasma membrane and generates 
smaller currents when stimulated25. Similarly, we found that CFTRΔTRL elicited a smaller change in fluorescence 
(Fig. 5A–F). However, the relative activation for CFTRΔTRL was greater than for wild-type CFTR for both forsko-
lin and isoproterenol while the adenosine response was significantly depressed, suggesting that deletion of CFTR’s 
C-terminus has a greater effect on the ability of adenosine over isoproterenol to stimulate CFTR (Fig. 5G).
We have previously shown that CFTR and A2BR (i) co-immunoprecipitated and underwent 
adenosine-dependent increases in FRET and (ii) that CFTR expression enhanced adenosine/A2BR-induced 
increases in cytosolic cAMP21. We examined the effect of cytoskeletal disruption on CFTR-A2BR interac-
tions. Pretreatment with the microtubule inhibitor colchicine (10 μM) had no effect on CFTR-A2BR basal 
or adenosine-induced FRET (12.9 ± 4.6% and 19.6 ± 4.2% respectively; n = 4 and 8). Cytochalasin D had no 
effect on basal CFTR-A2BR FRET levels, but completely attenuated the adenosine-dependent increase in FRET 
(Fig. 6A). In contrast, cytochalasin D had no effect on β2AR-CFTR FRET either basally, or post-isoproterenol 
(Fig. 6B). Cytochalasin D only affected the adenosine-induced increase in cAMP production in the presence 
of CFTR (Fig. 6C) and was without effect on cAMP levels in BHK cells. While cytochalasin D had no effect on 
isoproterenol-induced cAMP production in BHK cells, it significantly reduced enhanced agonist-induced cAMP 
production in BHKCFTR cells (Fig. 6D).
The C-terminal PDZ domain of A2BR is required for CFTR-dependent cAMP production. To 
differentiate between plasma membrane vs. intracellular CFTR/A2BR FRET, we used a CFTRgfp (donor) vs. 
A2BRmCherry (acceptor) FRET pair and performed acceptor-photobleaching FRET before and 5 min after aden-
osine exposure. This FRET pair exhibited significant basal FRET in the plasma membrane and underwent similar 
agonist-dependent FRET at the plasma membrane as in our previous studies with CFTRcfp and A2BRyfp21, 
suggesting that their use was valid (Fig. 7A,B). In contrast, we were unable to detect intracellular FRET between 
CFTRgfp and A2BRmCherry expressed in BHK cells (Fig. 7B). Using cAMP production as a secondary readout, 
we observed that CFTRgfp yielded a similar potentiation of adenosine-induced cAMP production as GFP-free 
CFTR (i.e. HA-CFTR; with a HA tag inserted in its 2nd extracellular loop) and that the placement of the gfp 
on either the C- or the N- termini did not affect CFTR-dependent cAMP production (Fig. 7). To probe the 
influence of CFTR’s C- terminus on adenosine-stimulated CFTR/A2BR association and cAMP production, we 
examined the effect of a CFTR mutant with a disrupted PDZ motif (L1480A)26,27. L1480ACFTR did not affect basal 
CFTR/A2BR FRET but abolished the adenosine-induced increase in FRET (Fig. 7B) and significantly reduced 
CFTR-dependent cAMP production (Fig. 7C), suggesting that CFTR’s C-terminal PDZ motif is critical for the 
CFTR-dependent enhancement of adenosine signaling.
Switching A2BR’s and β2AR’s C-termini affects their Interaction with CFTR. Unlike 
the adenosine-induced cAMP production, isoproterenol/β2AR-induced elevations in cAMP levels are 
CFTR-independent, and CFTR/β2AR FRET was also unchanged following stimulation with isoproterenol21. 
However, the C-termini of both GPCRs are predicted to contain PDZ-binding motifs. Thus, to test whether 
the C-termini of A2BR and β2AR affected their interaction with CFTR, we generated new constructs where we 
swapped the PDZ-binding motifs of these two GPCRs (Fig. 8A). While FRET between CFTRcfp and wild-type 
A2BRyfp increased upon adenosine stimulation, exchanging the last 4 C-terminal amino acids of A2BR with 
those from β2AR’s C-terminus abolished the adenosine-induced increase in FRET (i.e. A2BRGVGL to A2BRDSLL; 
Fig. 8B) and also abolished the CFTR-dependent increase in cAMP production (Fig. 8D). In contrast, while 
β2ARyfp did not increase the %FRET with CFTR after isoproterenol addition, exchange of β2AR’s C-terminus 
for that of A2BR (i.e. β2ARDSLL to β2ARGVGL) conferred an isoproterenol-dependent increase in FRET (Fig. 8C). 
Note that A2BRDSLL was still functional and increased cAMP levels above baseline (Fig. 8E). However, the increase 
was of a similar magnitude as β2AR, but less than A2BR (Fig. 8C). In contrast, β2ARGVGL–stimulated cAMP pro-
duction became CFTR-dependent and was significantly greater than that produced by wild-type β2AR (Fig. 8E).
forskolin, isoproterenol and adenosine respectively and their vehicle controls ± cytochalasin D.  
(D–F) Dose response curves for forskolin, isoproterenol and adenosine respectively ± cytochalasin D  
with wild-type CFTR or CFTRΔTRL without cytochalasin D. Note, in some cases, error bars were occluded 
by the graph symbols. (G) Bar graph showing the fold-stimulation (maximally stimulated/basal) taken 
from (D–F) for forksolin, isoproterenol and adenosine. Blue bars are control/wild-type CFTR, red bars are 
cytochalasin D-exposed/wild-type CFTR and black bars show ΔTRL. All data points are n = 12. *denotes 
significant difference to control or between curves fitted with the equation [Y = Bottom + (Top-Bottom)/
(1 + 10^((LogEC50 − X)))]. †denotes significant difference to other CFTRΔTRLs.
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Discussion
The interaction of CFTR with the actin cytoskeleton has been recognized. For example, actin disruption has 
been shown to both potentiate and inhibit CFTR activity depending on the experimental conditions28,29. It has 
previously been noted that CFTR expression affects actin organization in 16HBE cells22. We have found identical 
results in HEK293T cells and in our primary, well-differentiated HBECs (Fig. 1). We also found that this observa-
tion extends not only to actin, but also to ezrin, NHERF1 and NHERF2 and that only cellular localization but not 
total protein was affected (Fig. 1). Whilst we saw an increased fluorescence intensity near the apical plasma mem-
brane, total protein was not increased (Fig. 1). It is likely that the increased concentration of protein near the api-
cal membrane rather than an increased total amount of protein caused this increase in fluorescence. Similarly, we 
and others have observed an increase in stromal interacting protein 1 (STIM1) fluorescence when endoplasmic 
reticulum Ca2+ is depleted, which is due to STIM1 aggregation rather than an increase in total STIM1 protein lev-
els30,31. To further investigate this phenomenon, we looked at the effect of mutating CFTR’s C-terminus on actin 
and NHERF1 reorganization. Using confocal microscopy, we observed that CFTR’s C-terminal PDZ domain was 
required to affect F-actin organization and that CFTR with a disrupted PDZ domain (ΔTRLCFTR) was no longer 
able to influence either actin or NHERF1 organization and no longer co-localized with F-actin (Fig. 2A,B). To 
look at this effect in more detail, we used super resolution microscopy, which surpasses the diffraction limit of 
Figure 6. A2BR/CFTR FRET and cAMP production are dependent on an intact actin cytoskeleton. BHK 
cells were exposed to vehicle (0.1% DMSO) or 10 μM cytochalasin D (CytD). Open bars are controls. Closed 
bars, adenosine (ADO). Grey bars, isoproterenol (ISO). (A) The ADO-induced increase in A2BRyfp–CFTRcfp 
FRET was abolished by cytochalasin D (n = 10). (B) β2ARyfp–CFTRcfp FRET is not agonist dependent and not 
affected by cytochalasin D (n = 12). (C) Cytochalasin D abolishes CFTR potentiation of ADO-induced cAMP 
production in BHKCFTR cells and is without effect in BHK cells (n = 12). (D) Cytochalasin D had no effect on 
ISO-induced increases in cAMP levels in BHKCFTR cells, but significantly reduced cAMP production in BHK 
cells. *p < 0.05 different from vehicle. †p < 0.05 different ± cytochalasin D (n = 12).
www.nature.com/scientificreports/
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light and enables a resolution of ~30 nm2. Interestingly, the super resolution analysis revealed (i) discrete CFTR 
localization at the edge of the cell (e.g. the plasma membrane) that was distinct from intracellular CFTR and (ii) a 
close correlation between wild-type, but not CFTRΔTRL and the actin cytoskeleton (Fig. 2C,D). To the best of our 
knowledge, this is the first time that super resolution microscopy has been used to identify and localize CFTR. 
Again, using confocal microscopy to analyze surface CFTR, we were able to further highlight the association of 
CFTR with actin and indeed, it appears that surface CFTR’s expression closely follows that of actin (Fig. 3). Thus, 
there appears to be a complex interplay between CFTR and the scaffolding proteins that will require further study.
It has previously been shown that latrunculin, which disrupts actin assembly, attenuates CFTR mediated 
Cl− efflux22. Our data indicated that the effects of actin depolymerization on CFTR may also be dependent 
Figure 7. The C-terminus of CFTR is required for CFTR-A2BR interactions at the plasma membrane. 
(A) Typical pre-and post-bleach images obtained by confocal microscopy of gfp-tagged CFTR (green) and 
mCherry-tagged A2BR (red) expressed in BHK cells. Scale bar is 25 μm. (B) Mean FRET efficiency data. Left, 
plasma membrane FRET measured between A2BRmCherry and either wild-type CFTRgfp or the L1480A 
CFTRgfp mutant under basal or adenosine-stimulated conditions. All n = 7–9. Right, intracellular FRET 
between CFTRgfp and A2BRmCherry ± adenosine. Open bars, vehicle. Closed bars, FRET after 5 min exposure 
to 10 μM adenosine. (C) Intracellular cAMP levels under basal conditions (open bars) and following 5 min 
adenosine exposure (closed bars) in BHK cells endogenously expressing A2BR and either no CFTR, CFTR 
tagged with gfp on its C-terminus, extracellularly HA-tagged CFTR and following mutation of the C-terminus 
(L1480A). All n = 6. NT is non-transfected control. *p < 0.05 different from vehicle. †p < 0.05 different to wild-
type or different ± CFTR.
www.nature.com/scientificreports/
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on how CFTR is activated. That is, cytochalasin D prevented A2BR but not β2AR-dependent increases in ASL 
height (Fig. 4). However, several other factors can influence Cl− secretion in polarized HBECs. For example, 
ASL/Cl− secretion occurs under “open circuit conditions”. That is, for secretion to occur, ENaC must first be 
inhibited to hyperpolarize the apical membrane since the intracellular Cl− concentration is less than the ASL 
Cl− concentration32. Indeed, we have previously shown that adenosine-dependent stimulation of ASL height 
can be abrogated by activating ENaC33. Thus, we cannot exclude the possibility that cytochalasin D is affecting 
Figure 8. A2BR’s C-terminal PDZ motif confers selective enhancement of GPCR function in the presence 
of CFTR. (A) The last 4 amino acids on A2BR and β2AR are predicted PDZ-binding motifs. The cartoon 
depicts both wild-type A2BR and β2AR; A2BR where the last 4 amino acids were replaced with those from 
β2AR (A2BRDSLL); and β2AR with the last 4 amino acids from A2BR (β2ARGVGL). Mean changes in FRET 
between CFTRcfp and (B) wild-type A2BRGVGLyfp or A2BRDSLLyfp and (C) wild-type β2ARDSLLyfp and 
β2ARGVGLyfp measured in BHK cells. n = 7, 11, 12 and 14 for each pair respectively. Open bars, vehicle; closed 
bars, ADO; gray bars, ISO. Relative increase in intracellular cAMP levels (agonist/vehicle) for (D) A2BR and 
(E) β2AR transfected into BHKCFTR cells as indicated. N = 5, 11, 6 and 12 respectively. *p < 0.05 different from 
vehicle. †p < 0.05 different to wild-type or different ± CFTR.
www.nature.com/scientificreports/
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ENaC, or K+ channels to prevent ASL secretion. However, the adenosine-dependent decrease in halide-sensitive 
YFP (Fig. 5), the increase in CFTR-A2BR FRET (Fig. 6A) and the increase in adenosine-stimulated cAMP 
production (Fig. 6C) were all ablated when the cytoskeleton was disrupted. In contrast, the CFTR-β2AR ASL 
secretion (Fig. 4), FRET (Fig. 6B) and isoproterenol-stimulated cAMP production (Fig. 6D) were cytochalasin 
D-independent in CFTR-expressing cells. Surprisingly, in the absence of CFTR, β2AR/isoproterenol- cAMP pro-
duction was cytochalasin D-dependent and enhanced (Fig. 6D), suggesting that GPCR signaling is different in 
the absence of plasma membrane CFTR. Together, these data highlight the importance of both CFTR and the 
actin cytoskeleton in regulating A2BR and β2AR signaling and also suggest that these GPCRs signal differently 
to raise cAMP. The demonstration of similar effects of cytochalasin D in polarized HBECs as in our cell lines 
(HEK293T and BHK), suggests that our observations are relevant to more complex cell types, such as polarized 
epithelia. Cytochalasin D causes major cellular disruption. However, we could still generate isoproterenol and 
ATP-mediated ASL secretion and cAMP production after cytochalasin D exposure, suggesting that this exposure 
was not toxic and that the HBECs could maintain sufficient polarity and function to generate ASL secretion.
FRET is typically taken as a change in distance between two fluorophores and changes in FRET can be approx-
imately calculated using the equation r = Ro * [(1/E%) − 1]^(1/6)34. Thus, with cytochalasin D exposure, we saw 
an ~15% decrease in FRET between CFTR and the A2BR, which could correspond to a change of ~15 Å. However, 
changes in FRET can also be caused by changes in orientation, rather than distance of the 2 fluorophores. As 
such, any FRET data has to be interpreted cautiously. In our opinion, the safest interpretation of the FRET data is 
that adenosine causes some movement between CFTR and A2BR that is abrogated by cytochalasin D. There was 
little intracellular FRET and significantly more plasma membrane FRET between CFTR and A2BR, even under 
basal conditions (Fig. 7). These data suggest that CFTR and A2BR do not associate intracellularly, and only do so 
when they reach the plasma membrane. It has been suggested that placing GFP on CFTR’s C-terminus affects its 
PDZ-binding interactions. Using cAMP production as a read out, we compared CFTR gfpCFTR (i.e. N-terminal 
GFP) or CFTRgfp (i.e. C-terminal GFP). Both constructs still elicited an enhanced adenosine-dependent increase 
in intracellular cAMP levels (Fig. 7C), suggesting that the CFTR-A2BR interaction was not significantly altered.
PDZ-interactions play a key role in anchoring CFTR, β2AR and A2BR to the actin cytoskeleton12,13. For exam-
ple, NHERF1 has two PDZ-binding domains that may link CFTR and β2AR in macromolecular complexes13 and 
alterations to the C-terminal PDZ-binding motif of CFTR affects its stability in the plasma membrane35–37. To test 
whether CFTR’s C-terminus was important for the CFTR-A2BR interaction, we utilized a mutant CFTR whose 
C-terminus was altered so as to not bind PDZ domains (L1480ACFTRgfp). This mutant has previously been shown to 
traffic to the plasma membrane and to conduct Cl− 27. However, the CFTR-A2BR FRET and the CFTR-dependent 
increase in cAMP production after adenosine exposure were again significantly diminished (Fig. 7A–C), sug-
gesting that CFTR’s PDZ domain is crucial for this interaction. The role of PDZ binding in enhancing A2BR 
function was underscored by our GPCR domain swapping experiments (Fig. 7). Both A2BR and β2AR have 
C-terminal PDZ motifs (Fig. 8A). However, A2BR has a type 2 motif (i.e. X-Φ-X-Φ, where X is any amino 
acid and Φ is any hydrophobic amino acid) while β2AR has a type 1C-terminal PDZ motif (i.e. X-S/T-X-Φ)38. 
Interestingly, domain swapping did not alter basal levels of FRET for either GPCR and did not fully ablate 
adenosine-stimulated cAMP production, suggesting that there is a basal level of A2BR-CFTR interaction that is 
independent of PDZ binding (Fig. 8).
cAMP compartmentalization in polarized epithelia has been well described39,40. This was initially inferred 
by the often precise location of key players in the cAMP pathway. For example, PKA is attached to the actin 
cytoskeleton via NHERF1 and ezrin41 and phosphodiesterases that degrade cAMP are also known to be local-
ized sub-apically in several different epithelia including airways42. More recently, using genetically encoded, 
FRET-based cAMP sensors, it has been shown that sub-apical cAMP levels change differentially to cytoplasmic 
cAMP following stimulation of adenylate cyclase with forskolin, in a CFTR-dependent manner43. We have pre-
viously shown that CFTR enhances cAMP production by A2BR, but not by β2AR, likely by a CFTR-dependent 
insertion of A2BR in the plasma membrane, although the mechanism wasn’t fully understood21. Our current data 
suggest that CFTR’s effects on the cytoskeleton were responsible for specifically increasing A2BR-dependent sig-
naling. Naren et al. have previously studied the interactions between CFTR, GPCRs and the actin cytoskeleton20. 
Using Cos-7 cells, they found a strong functional PDZ-dependent interaction between β2AR and CFTR, but 
little actin/PDZ dependency for A2BR. We do not know why we found different results to them. However, Naren 
et al. only tested the interactions at one stimulating dose, whilst we generated full dose responses and compared 
the curves rather than individual data points (Fig. 5). Alternatively, there may be a species difference between the 
simian-derived Cos-7 cells used by Naren et al. and the human HEK293T cells used in this study (Fig. 5).
In conclusion, we have demonstrated that CFTR’s C-terminus interacts with different GPCRs and also helps 
shape the actin cytoskeleton. These, and related data, point to an important role for CFTR in cell signaling21,22, the 
cells of CF patients with severe mutations likely have altered signaling abilities that are still only being appreciated. 
Thus, while CFTR/A2BR interactions have been shown to affect cAMP production, ciliary beating and cytokine 
secretion21, the impact of CFTR-dependent cell signaling on CF disease pathogenesis remains to be determined.
Methods
Cell Isolation and Culture. Since transfection efficiencies are very low in primary HBECs, we have used 
HEK293T cells as our main cell line for this study. Where biochemical or imaging experiments necessitated the 
use of a cell line with high CFTR expression, we used BHK cells that stably express “exotope CFTR”, which has an 
extracellular HA tag inserted into CFTR’s 3rd extracellular loop44. Where transfection was not required, we used 
normal vs. CF HBECs. Human donor lungs and excised recipient lungs were obtained at the time of transplan-
tation from portions of main stem or lumbar bronchi and cells were harvested by enzymatic digestion in accord-
ance with a protocol that was approved by the UNC Institutional Review Board45. Informed consent was obtained 
from authorized representatives of all organ donors and from all patients. All CF HBECs were obtained from 
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DF508 homozygous patients. Baby Hamster Kidney (BHK) cells were cultured in DMEM/F12 media containing 
5% Fetal Bovine Serum (FBS) at 37 °C in 5% CO2. Human embryonic kidney (HEK293T) cells were cultured in 
DMEM media containing 10% Fetal Bovine Serum (FBS) at 37 °C in 5% CO2. Both cell types were cultured on 
glass slides for imaging or 6-well plastic plates for biochemical experiments as described21. If required, HEK293T 
cultures that were ~75% confluent were transfected for ~6 h using Lipofectamine (Invitrogen, Carlsbad, CA, 
USA) as per the manufacturer’s instructions. The transfection reagents were then removed and the cultures were 
used for experimentation 24–48 h later.
Förster resonance energy transfer (FRET). Acceptor-photobleaching FRET was measured with a TE300 
microscope (Nikon Instruments, Melville, NY, USA) using a 60 × 1.2 NA water objective lens, switchable fil-
ter wheels (Ludl, Hawthorne, NY, USA) and an Orca CCD camera (Hammamatsu, Bridgewater, NJ, USA) for 
CFP/YFP FRET pair, or with a SP5 confocal microscope (Leica Microsystems, Buffalo Grove, IL, USA) with a 
63 × 1.3 NA glycerol objective lens for the GFP/mCherry FRET pair as previously described21,46. In brief, the 
donor (eGFP) was excited at 488 nm and emission collected from 495 nm to 549 nm and the acceptor (mCherry) 
was excited at 561 nm and emission collected from 580 nm to 654 nm. The acceptor was then photobleached until 
<5% of the original image intensity remained, then donor and acceptor fluorescence were remeasured. All image 
analysis was performed using Image J (NIH Freeware). The 4 images in each set (e.g. pre and post bleach for 
acceptor and donor) were opened as a stack and corresponding regions of interest were drawn around the bleach 
region in the 4 images. After the image intensities were measured, to determine the FRET efficiency (%E), the 
following equation was used: ((donorpostbleach-donorprebleach)/donorpostbleach)*100.
cAMP Measurements. After vehicle or agonist addition, media was aspirated and cells were lysed with 
0.1N HCl, centrifuged at 10,000 × g for 10 min and the supernatants were assayed using an enzyme immunoassay 
kit (Enzo Lifesciences). Pellets were assayed for protein content using the BCA method (Pierce) as described 
previously21.
Halide-sensitive YFP assay. HEK293T cells were transfected with CFTR and YFP on 10 cm dishes, 
trypsinized, reseeded in 384 well plates at a density of 10,000 cells per well and assayed 24 h later using the method 
of Galietta et al.24. In brief, cells were bathed in PBS++ and baseline fluorescence was recorded at 0.2 Hz using a 
Tecan M1000 multimode plate reader (Tecan) at 37 °C. PBS++ was then exchanged for a modified PBS where 
100 mM NaCl was replaced with an equal concentration of NaI and agonist or vehicle. Fluorescence was then 
acquired at 0.2 Hz until a new steady state had been reached. In some cases, cells were incubated with 1 μM 
Cytochalasin D for 30 minutes prior to starting the assay.
Western Blotting. Cells were lysed with 1% NP40 buffer on ice. Cell lysates were centrifuged at 10,000 x g for 
10 min at 4 °C, and supernatants were collected. Cell lysates (25 μg) were loaded, separated on 3–8% Tris-acetate 
minigels and transferred to PVDF membrane (Invitrogen) using an iBlot dry transfer system as described21,46. 
After the gels were run, they were quartered and each portion, which contained a normal and a CF lane, was 
separately probed for either actin, ezrin, NHERF1 and NHERF2. All western blots were read using a BioRad 
Chemidoc system.
Immunofluorescence. For surface labelling, HA-CFTR, BHKCFTR cultures were blocked for 1 h with 1% 
BSA and 1% normal goat serum (NGS) at 4 °C in BHK media. After this time, cells were incubated in the same 
blocking solution with rabbit anti-HA polyclonal antibody (1:300) for an additional 1 h at 4 °C. Intact cells 
were fixed for 10 min in 4% paraformaldehyde before permeablization with 0.1% Triton-X and staining with 
Phalloidin-561 (1:1000) as described44.
For standard immunofluorescence, HBECs and HEK293T cells were fixed at room temperature with 4% PFA 
for 30 min and blocked overnight in BSA/NGS before labelling with primary and secondary antibodies and/or 
phalloidin at room temperature. When changing between antibodies, all cells were washed for 4 × 5 min in PBS. 
All images were analyzed using Image J by placing regions of interest around the apical membrane to obtain the 
intensity.
The Pearson Correlation/colocalization plugin in the ImageJ analysis program was used to calculate the 
co-localization for the signal intensity of the green (CFTR) and red channels (F-actin) as described47. Results for 
the Pearson’s correlation coefficient r describe the linear relationship between the CFTR and F-actin channels. 
A positive correlation is reflected by the coefficient r value greater than 0 and a negative correlation when the 
coefficient r value is less than 0.
Super resolution microscopy. HEK293T cells were fixed in 4% paraformaldehyde before permeabiliza-
tion with 0.25% Tween20. Cells were then blocked with 10% normal goat serum and 1% BSA in PBS-Tween for 
1 h at room temperature and 5 h at 4 °C. The cells were incubated with primary antibodies for rabbit anti-actin 
(Millipore) and mouse anti-CFTR (UNC, amino acids 1204–1201) at 1:300 dilution at 4 °C overnight. The 
cells were then incubated with secondary antibodies, phalloidin-488 goat anti-mouse (Life Technologies) and 
DyLight-633 goat anti-rabbit (Thermo scientific), at a 1:2000 dilution for 1 h in 4 °C. The coverslips were mounted 
on single concavity slides using 50 mM β-Mercaptoethylamine in PBS, pH 7.4 as the mounting solution, with 
the edges of the coverslip sealed with Twinsil silicone glue (Leica). Super resolution fluorescence imaging was 
performed on a Leica SR-GSD-3D localization microcopy using a 160x oil-immersion objective. The image pro-
cessing package, Leica LAS AF 2.6.1, was used for image acquisition.
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Measurements of airway surface liquid height. PBS (20 μl) containing 2 mg/ml rhodamine-dextran 
(10 kDa; Life Technologies) was added to cultures at the start of the experiment. In some cases, after addition of 
PBS, all available fluid was aspirated with a Pasteur pipette to bring ASL volume down to minimal levels. Five 
predetermined points (one central, four 2 mm from the edge of the culture) were XZ scanned using a confocal 
microscope (Leica SP5; glycerol 63X immersion lens) as described23. Cultures were returned to the incubator 
between time points. For all studies, ~100 μl perfluorocarbon (PFC) (FC-77; 3 M) was added mucosally during 
imaging to prevent evaporation of the ASL. As previously described, PFC does not displace ASL and does not 
affect ASL height, ion transport or mucus transport48. ASL heights were then analyzed using ImageJ as described 
by placing regions of interest around the ASL to determine the height.
Solutions and Chemicals. Unless noted, all chemicals were purchased from Sigma-Aldrich. The fol-
lowing antibodies were used: Mouse anti-Ezrin (BD Biosciences), rabbit anti-NHERF2 (Sigma-Aldrich), rab-
bit anti-EBP50 and anti-HA (Abcam), rabbit anti-Actin (Millipore). Secondary antibodies were raised in 
goat and purchased from Life Technologies and Jackson ImmunoResearch Laboratories. Phalloidin-568 (Life 
Technologies) was made up at 2 mg/ml in methanol and used at a final concentration of 1 μg/ml. During exper-
iments, cells were maintained in a modified Ringer solution containing (mM): 130 NaCl, 5.1 KCl, 1.2 CaCl2, 1.2 
MgCl2, 10 mM HEPES, 10 glucose, pH 7.4.
Statistical Methods. All data are presented as mean ± standard error and data was analyzed using Instat3 
or Prism (Graphpad). Data were inspected by analysis of variance to test whether or not they were derived from 
a single population that was normally distributed. Statistical significance between groups was assessed using 
paired or unpaired t test as appropriate. If data were not normally distributed then the Mann-Whitney U test or 
Wilcoxin matched pairs test were used as appropriate. Values of n refer to the number of subjects or the number of 
cultures used in each group. For HBECs, a minimum of 4 different donors supplied cultures for each experiment. 
For experiments utilizing HEK293T and BHK cells, all experiments were performed on at least three separate 
occasions.
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